NCT03934398

Brief Summary

The investigators aim to determine the association of dietary intake on cardiovascular disease risk factors among children with overweight and obesity who are being evaluated for elevated blood pressure. The investigators will also investigate for predictors of vascular function and determine if predictors vary by level of sodium intake.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
41

participants targeted

Target at P25-P50 for all trials

Timeline
Completed

Started Apr 2019

Typical duration for all trials

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

April 10, 2019

Completed
19 days until next milestone

First Submitted

Initial submission to the registry

April 29, 2019

Completed
2 days until next milestone

First Posted

Study publicly available on registry

May 1, 2019

Completed
3.1 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

May 31, 2022

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

May 31, 2022

Completed
Last Updated

June 22, 2022

Status Verified

June 1, 2022

Enrollment Period

3.1 years

First QC Date

April 29, 2019

Last Update Submit

June 21, 2022

Conditions

Outcome Measures

Primary Outcomes (5)

  • Arterial stiffness as assessed by Pulse wave velocity

    This will be determined from Pulse wave velocity (m/sec) done at the study visit

    1 day

  • Arterial stiffness as assessed by Ambulatory Arterial Stiffness Index (AASI)

    The Ambulatory Arterial Stiffness Index will be determined from data obtained from vascular measures and during 24-hour ambulatory blood pressure monitoring. Arterial stiffness increases as the regression slope approaches 0 and the AASI approaches 1.

    1 day

  • Arterial stiffness as assessed by Augmentation Index

    The Augmentation Index (measured as a percentage) will be determined from a vascular assessment and data obtained during 24-hour ambulatory blood pressure monitoring. A greater Augmentation Index represents a stiffer, less compliant vessel.

    1 day

  • Endothelial function as assessed by Laser Doppler flow perfusion

    The percent change in mean blood flow will be determined from Laser Doppler flow perfusion measurements obtained using a heating protocol.

    1 day

  • Mean Blood pressure (mmHg)

    Mean daytime systolic blood pressure in millimeters of mercury (mmHg) will be determined from 24-hour blood pressure monitoring.

    1 day

Secondary Outcomes (3)

  • Pediatric Adverse Childhood Events (ACEs) score

    1 day

  • Children's Emotion Management Scale (CEMS) score

    1 day

  • Behavior Assessment for Children (BASC) score

    1 day

Study Arms (1)

ReNEW Clinical Cohort

Individuals evaluated in the ReNEW Clinic at Johns Hopkins University who join the ReNEW Clinic Cohort Study are eligible for this cross-sectional study. Tests will be done for all participants which includes Cardiovascular Assessments, Actigraphy and Laboratory assessments.

Diagnostic Test: Cardiovascular AssessmentsDiagnostic Test: ActigraphyDiagnostic Test: Laboratory assessmentsDiagnostic Test: Emotional/Behavioral Assessments

Interventions

Participants will undergo the following cardiovascular assessments: 24-hour blood pressure monitoring, arterial stiffness measurements, endothelial function measurements.

ReNEW Clinical Cohort
ActigraphyDIAGNOSTIC_TEST

Participants will wear an actigraph device for 7 days to measure participant's activity and sleep.

ReNEW Clinical Cohort
Laboratory assessmentsDIAGNOSTIC_TEST

Participants will provide blood and urine samples for laboratory assessments.

ReNEW Clinical Cohort

Participants and parents will fill out questionnaires for emotional/behavioral assessments

ReNEW Clinical Cohort

Eligibility Criteria

AgeUp to 22 Years
Sexall
Healthy VolunteersNo
Age GroupsChild (0-17), Adult (18-64)
Sampling MethodNon-Probability Sample
Study Population

Children and young adults up to 22 years of age who have overweight or obesity and elevated blood pressure, and were referred to the ReNEW Clinic for evaluation and treatment of elevated blood pressure.

You may qualify if:

  • Overweight or obese
  • Elevated blood pressure
  • Referred to the ReNEW Clinic at Johns Hopkins University for evaluation and treatment of elevated blood pressure.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Johns Hopkins School of Medicine Division of Pediatric Nephrology

Baltimore, Maryland, 21287, United States

Location

MeSH Terms

Conditions

PrehypertensionHypertensionOverweightObesity

Interventions

Actigraphy

Condition Hierarchy (Ancestors)

Vascular DiseasesCardiovascular DiseasesOvernutritionNutrition DisordersNutritional and Metabolic DiseasesBody WeightSigns and SymptomsPathological Conditions, Signs and Symptoms

Intervention Hierarchy (Ancestors)

Monitoring, PhysiologicDiagnostic Techniques and ProceduresDiagnosisAccelerometryInvestigative Techniques

Study Officials

  • Tammy M Brady, M.D., PhD.

    Johns Hopkins University Division of Pediatric Nephrology

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
CROSS SECTIONAL
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

April 29, 2019

First Posted

May 1, 2019

Study Start

April 10, 2019

Primary Completion

May 31, 2022

Study Completion

May 31, 2022

Last Updated

June 22, 2022

Record last verified: 2022-06

Locations